Sysmex in Brief
The worldwide market for testing is growing.
Healthcare, Sysmex's business domain, is heralded as an area of growth in the 21st century. Within this category, testing is also an expanding market.
Advanced countries with aging populations seek to curtail rises in healthcare spending, and demand for preventive medicine is growing accordingly. Testing plays an increasingly important role in the prevention and early detection of disease.
At the same time, the level of healthcare in China, India, Brazil, Russia and other emerging countries is rising as their economies grow, causing demand for testing to accelerate rapidly.
Based on this scenario of aging populations in advanced countries and economic growth in emerging countries, we expect the market for testing to expand worldwide.
We plan to offer testing that delivers new value through advanced technologies.
Sysmex will concentrate on creating new testing and diagnostic technologies that leverage the expertise it has cultivated in the in vitro diagnostics domain.
Expectations are growing about the realization of personalized medicine that could provide treatments optimized for individual patients, improving patient quality of life and curtailing medical expenses. Sysmex is contributing to the development of personalized medicine through R&D on new technologies offering higher levels of sensitivity than in the past.